Status | Study |
Recruiting |
Study Name: A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications Condition: Epilepsy Date: 2015-03-31 Interventions: Drug: Lacosamide Tablet |
Enrolling by invitation |
Study Name: Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic Clonic Seizures Condition: Epilepsy Date: 2015-03-31 Interventions: Drug: Lacosamide Tablet |
Withdrawn |
Study Name: Treatment Resistant Epilepsy and N-Acetyl Cysteine Condition: Autistic Disorder Seizures Irritability Date: 2014-02-03 Interventions: Drug: N-Acetyl Cysteine (NAC) NAC will be started at 500 mg by mouth twice daily for the first 2 weeks, |
Completed |
Study Name: Topiramate Bioequivalence Study Brazil - Fast Condition: Epilepsy, Tonic-Clonic Date: 2011-09-21 Interventions: Drug: Topiramate coated tablet |
Completed |
Study Name: Blinking and Yawning in Epilepsy: The Role of Dopamine Condition: Idiopathic Generalized Epilepsy Date: 2011-06-14 Interventions: Other: Apomorphine (Experimental product) Dosage Form: Inj |
Active, not recruiting |
Study Name: Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy Condition: Epilepsy Focal Epilepsy Generalized Date: 2011-03-07 Interventions: Other: Modified Atkins diet treatment Eat a diet containing 16 grams of carbohydrates per day, maximize |
Completed |
Study Name: Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy Condition: Epilepsy Date: 2010-05-05 Interventions: Drug: Lacosamide Lacosamide is supplied as 50 mg, 100 mg, 150 mg, and 200 mg tablets. Subjects will begi |
Completed |
Study Name: Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy Condition: Epilepsy Date: 2010-05-05 Interventions: Drug: Lacosamide Lacosamide was supplied as 50 mg and 100 mg tablets. The starting Lacosamide dose was t |
Completed |
Study Name: Genetic Disease Gene Identification Condition: Congenital Vertical Talus Familial Encephalopathy With Neuroserpin Inclusion Bodies Date: 2009-06-08 |
Terminated |
Study Name: Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy Condition: Epilepsy Date: 2008-06-03 Interventions: Drug: Zonisamide |